03448nam 2200685 a 450 991078313940332120231110230259.01-280-19787-097866101978731-4051-4606-01-4237-1777-5(CKB)1000000000009157(EBL)233112(OCoLC)475939740(SSID)ssj0000257608(PQKBManifestationID)11193224(PQKBTitleCode)TC0000257608(PQKBWorkID)10254089(PQKB)11471854(Au-PeEL)EBL233112(CaPaEBR)ebr10033058(OCoLC)437147416(Au-PeEL)EBL5247562(CaONFJC)MIL19787(Au-PeEL)EBL7104542(MiAaPQ)EBC233112(EXLCZ)99100000000000915720030609d2002 uy 0engur|n|---|||||txtccrThe textbook of pharmaceutical medicine[electronic resource]4th ed. /edited by John P. Griffin and John O'Grady.London BMJ Books20021 online resource (896 p.)New York Academy of Sciences Includes index.Previous ed.: / edited by J.P. Griffin, J. O'Grady, P.F. D'Arcy. Belfast : Queen's University of Belfast, c1998.0-7279-1523-1 Contents; Contributors; Preface; Acknowledgements; The editors; 1: Discovery of new medicines; 2: Pharmaceutical development; 3: Toxicity testing; 4: Exploratory development; 5: Clinical pharmacokinetics; 6: Clinical trials and good clinical practice; 7: Medical statistics; 8: Development of medicines: full development; 9: The medical department; 10: Medical marketing; 11: Information and promotion; 12: The supply of unlicensed medicines for particular patient use; 13: Legal and ethical issues relating to medicinal products; 14: The safety of medicines15: The development of the control of human medicines in Europe from classical times to the year 200016: Technical requirements for registration of pharmaceuticals for human use: the ICH process and the common technical document; 17: The regulation of drug products by the United States Food and Drug Administration; 18: The US FDA in the drug development, evaluation and approval process; 19: Regulatory and clinical trial systems in Japan; 20: Economics of healthcare; 21: Controls on NHS medicines prescribing and expenditure in the UK (a historical perspective); Appendix 1; Appendix 2PRESCRIPTION MEDICINES CODE OF PRACTICE AUTHORITY Constitution and ProcedureIndexThis edition has totally revised chapters on drug regulation in the USA, with new contributor, Dr Peter Barton Hutt formerly FDA Special Counsel. New contributions regarding pharmaco-economics are covered in two new chapters.New York Academy of Sciences Pharmaceutical chemistryPharmacologyPharmaceutical chemistry.Pharmacology.615.1Griffin J. P(John Parry)857365O'Grady John857366MiAaPQMiAaPQMiAaPQBOOK9910783139403321The textbook of pharmaceutical medicine3703835UNINA